Thanks kmcarr for your verification 
-
-
Thanks for your explanation in detail, pbluescript
You are very helpful ^^
Do you familiar with "FPKM"?
Based on isoforms.fpkm_tracking and genes.fpkm_tracking, how can I identify whether which transcript or gene is highly expressed, normal, lower expressed in an organism?
For FPKM value, is it I should consider how raw input read (*.fastq) form or assembly as transcript?
I just quite confusing the exact meaning of "Isoform-level relative abundance in Fragments Per Kilobase of exon model per Million mapped fragments".
Can you just show me with a simple example?
Cufflink assembly result only shown those protein-coding transcript, am I right?
It don't shown any non-protein-coding transcript, snRNA, ncRNA,etc, am I right?
Thanks again for advice.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...Today, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment